Wearable Cardioverter Defibrillators Market Share

Request Free Sample Copy

Report ID: 874
Published Date: Jan 03, 2025
Report Format: PDF, PPT

Buy Now

North American Market Forecast

North America industry is expected to hold largest revenue share of 38% by 2037. As a result, more resources are available in the region for research and development of more advanced, and reliable wearable cardioverter defibrillators which would also make these devices cost-effective in the region. In 2021, U.S. health spending climbed by more than 2% to reach over USD 4 trillion.

APAC Market Statistics

The APAC wearable cardioverter defibrillators market is estimated to be the second largest, during the forecast timeframe led by increase in investment towards the medical device sector from government and private entities to maintain the highest quality of services. The Indian government supports the production of medical devices in the country by offering various programs and subsidies under several ministries which has spread the word in the community about the value of leading a healthy lifestyle and the right of everyone to get high-quality medical care. This has led to an increase in demand for various advanced medical devices such as wearable cardioverter defibrillators in the region.

Wearable Cardioverter Defibrillators Market Demand

Browse key industry insights with market data tables & charts from the report:

Wearable Cardioverter Defibrillators Market Size & Share | Growth Trends 2037

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of wearable cardioverter defibrillators is evaluated at USD 274.58 million.

The wearable cardioverter defibrillators market size was valued at USD 254.06 million in 2024 and is expected to reach USD 826.65 million by 2037, expanding at around 9.5% CAGR during the forecast period i.e., between 2025-2037. Rising incidence of heart attacks across the globe and growing technological advancement in cardiology will drive the market growth.

North America industry is expected to hold largest revenue share of 38% by 2037, impelled by rising funding in the healthcare industry in the region.

The major players in the market are ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company., and others.

The market in the North American region is projected to hold the largest market share by the end of 2037 and provide more business opportunities in the future.